National Disease Research Interchange

NDRI is very pleased to share that after eight years of advocacy efforts by the Center for Organ Recovery and Education (CORE) and the Gift of Life Donor Program of Philadelphia, lawmakers unanimously passed the Donate Life PA Act (SB 180) on Wednesday, October 10, 2018.

Bill Leinweber, President and CEO of National Disease Research Interchange (NDRI) admits that NDRI’s work is complicated, because medical research is complex. For nearly 40 years, NDRI has accepted the challenge of meeting increasing demands of the medical research community, who rely on high-quality, healthy, and diseased biospecimens to conduct lifesaving research.

The National Disease Research Interchange (NDRI) has been awarded more than $800,000 by the National Institutes of Health (NIH). The supplemental awards provide support for NDRI to serve as a human biospecimen resource for research focused specifically on Alzheimer’s disease, Autism Spectrum Disorder (ASD) and HIV/AIDS. The three awards are supplements to NDRI’s Human Tissues and Organs for Research Resources (HTORR) program which has been supported by the NIH since 1987.

“Support from the NIH affirms the strong value of our mission,” said Gene Kopen, PhD, NDRI’s Senior Vice President for Strategic Initiatives and principal investigator for the HTORR grant. “As an organization, NDRI has demonstrated the capacity to leverage this support to enable a broad range of complex research projects requiring human organs and tissues.”

Read NDRI's 2018 Research Nexus for a recap of our Service to Science Awards Dinner, an exciting update on programs and initiatives, and learn how NDRI investigators are accelerating scientific discoveries!

NDRI’s 2018 Service to Science Awards Salute Biomedical Research Partnerships